CESTAT Tribunal Reverses Denial of Cenvat Credit, Sets Precedent for Non-Manufacturing Activities

The Appellate Tribunal CESTAT NEW DELHI reversed the denial of Cenvat credit on inputs/raw materials for non-manufacturing activities, citing the appellant's payment of central excise duty on the final product. Despite the lack of manufacturing, the duty paid exceeded the Cenvat credit utilized, resulting in a revenue-neutral outcome. Relying on the precedent set in Narmada Chematur Pharmaceuticals Ltd., the Tribunal set aside the orders denying the credit and allowed the appeals, granting relief to the appellant. The Tribunal also rejected a pass-over request due to the appellant's representative's lateness, emphasizing the need to proceed with the case promptly.

---

---

Issues: Denial of Cenvat credit on inputs/raw materials due to non-manufacturing activity.

The judgment by the Appellate Tribunal CESTAT NEW DELHI, delivered by Ms. Archana Wadhwa, addressed the issue of denying Cenvat credit on duty paid inputs/raw materials when the appellant engaged in activities like cutting HR/CR coils into sheets or slitting into strips, considered non-manufacturing. The lower authorities had disallowed the credit, arguing that without manufacturing activity, credit couldn't be availed. However, the appellant had paid central excise duty on the final product using the disputed credit. The Tribunal noted that the appellant had discharged duty on the final product, even if no manufacturing occurred, and the duty paid exceeded the Cenvat credit utilized. This led to the reversal of the entire Cenvat credit, creating a revenue-neutral situation. The Tribunal cited the Apex Court decision in Narmada Chematur Pharmaceuticals Ltd. [2005 (179) ELT 276 (SC)] to support their decision, emphasizing that the situation was covered by numerous precedent decisions. Consequently, the impugned orders denying the credit were set aside, and the appeals were allowed, granting relief to the appellant.

In this judgment, the Tribunal rejected a request for pass over due to the appellant's representative being late, emphasizing the time constraints and the position of the case on the list. They proceeded to decide the appeal, considering the issue's coverage by multiple precedent decisions. The Tribunal highlighted that the duty paid on the final product exceeded the Cenvat credit availed by the appellant, resulting in a reversal of the entire credit. This action was deemed revenue-neutral and aligned with the principles established in the Narmada Chematur Pharmaceuticals Ltd. case. The decision to set aside the impugned orders and allow the appeals was made based on these considerations, providing consequential relief to the appellant.

---